Rocket Lab Reports Nov. 9. Here's What I'd Need to See Before Buying the Stock.

RKLB reports Q3 results on Nov. 9, and the stock enters the print down 61% from its May peak. The driver: the Neutron rocket's first flight has slipped to 2027.

The numbers: Forecast revenue is $250-265 million, a 61-71% year-over-year jump. Adjusted EBITDA is expected to show a loss of $17-23 million. At 38x sales, the market is still paying a steep multiple for a business that remains unprofitable on that measure.

The setup: The Motley Fool analyst says growth alone won't trigger a purchase. Two conditions matter: visible progress on the replacement dome for testing in Q1 2027, and continued loss reduction. Interpretation: with revenue growth already forecast above 60%, the bar for this print is less about the top line and more about whether Neutron's timeline stops slipping and losses keep narrowing.

The 61% drawdown shows how heavily the stock is priced on Neutron's schedule. A 38x sales multiple leaves little room for another delay, while credible dome progress could reset sentiment. This is an interpretation of the evidence, not a forecast.